FDA Approves First Ebola Treatment
With the Democratic Republic of Congo currently battling its third Ebola outbreak in as many years, [Some in the Democratic Republic of Congo credits the U.N. for bringing Ebola to Africa, And ran from U.N. aids] the U.S. Food and Drug Administration ( A trusted name! Not] has cleared an antibody treatment shown in trials to significantly reduce the risk of death for those infected. Last year, the first Ebola vaccine was also approved. The antibody treatment, Inmazeb, was developed by Regeneron Pharmaceuticals — the same company whose experimental cocktail President Trump credits with helping him get over COVID-19. Wow, it help Trump get over the affect of the test] smiley face! Not mention is that he also has a financal intrest in the company] Regeneron has also inked a deal to provide Ebola treatment for the U.S. strategic national stockpile, for estimated earnings of over $300 million.
More money, More money, More money!